Jacques Joubert

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 26

Top Topics

Molecular Docking

Transcription Factor

Structure Activity Relationship

Top Venues

Journal of pharmaceutical policy and practice

Pharmaceutical medicine

Molecules (Basel, Switzerland)

Mini reviews in medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Ayodeji O Egunlusi, Sarel F Malan, Vitalii A Palchykov, Jacques Joubert
Calcium Modulating Effect of Polycyclic Cages: A Suitable Therapeutic Approach Against Excitotoxic-induced Neurodegeneration. Mini reviews in medicinal chemistry (2024)
Ayodeji Olatunde Egunlusi, Jacques Joubert
NMDA Receptor Antagonists: Emerging Insights into Molecular Mechanisms and Clinical Applications in Neurological Disorders. Pharmaceuticals (Basel, Switzerland) 17 (5) (2024)
Ayodeji Olatunde Egunlusi, Jacques Joubert
NMDA Receptor Antagonists: Emerging Insights into Molecular Mechanisms and Clinical Applications in Neurological Disorders. Pharmaceuticals (Basel, Switzerland) 17 (5) (2024)
Ayodeji O Egunlusi, Sarel F Malan, Vitalii A Palchykov, Jacques Joubert
Calcium Modulating Effect of Polycyclic Cages: A Suitable Therapeutic Approach Against Excitotoxic-induced Neurodegeneration. Mini reviews in medicinal chemistry 24 (13) (2024)
Lerato Moeti, Madira Litedu, Jacques Joubert
The Implementation of a Risk-Based Assessment Approach by the South African Health Products Regulatory Authority (SAHPRA). Pharmaceutical medicine 37 (1) (2023)
Lerato Moeti, Madira Litedu, Jacques Joubert
The Implementation of a Risk-Based Assessment Approach by the South African Health Products Regulatory Authority (SAHPRA). Pharmaceutical medicine (2023)
Lerato Moeti, Madira Litedu, Jacques Joubert
Regulatory registration timelines of generic medicines in South Africa: Assessment of the performance of SAHPRA between 2011 and 2022. Journal of pharmaceutical policy and practice 16 (1) (2023)
Lerato Moeti, Madira Litedu, Jacques Joubert
Regulatory registration timelines of generic medicines in South Africa: Assessment of the performance of SAHPRA between 2011 and 2022. Journal of pharmaceutical policy and practice 16 (1) (2023)
Lerato Moeti, Madira Litedu, Jacques Joubert
The Implementation of a Risk-Based Assessment Approach by the South African Health Products Regulatory Authority (SAHPRA). Pharmaceutical medicine 37 (1) (2023)
Lerato Moeti, Madira Litedu, Jacques Joubert
The Implementation of a Risk-Based Assessment Approach by the South African Health Products Regulatory Authority (SAHPRA). Pharmaceutical medicine 37 (1) (2023)
Lerato Moeti, Madira Litedu, Jacques Joubert
Regulatory registration timelines of generic medicines in South Africa: Assessment of the performance of SAHPRA between 2011 and 2022. Journal of pharmaceutical policy and practice 16 (1) (2023)
Lerato Moeti, Madira Litedu, Jacques Joubert
The Implementation of a Risk-Based Assessment Approach by the South African Health Products Regulatory Authority (SAHPRA). Pharmaceutical medicine 37 (1) (2023)
Lerato Moeti, Madira Litedu, Jacques Joubert
Regulatory registration timelines of generic medicines in South Africa: Assessment of the performance of SAHPRA between 2011 and 2022. Journal of pharmaceutical policy and practice 16 (1) (2023)
Ayodeji O Egunlusi, Jacques Joubert
Ever-expanding landscape: Alzheimer's - new targets and new patents. Pharmaceutical patent analyst 11 (5) (2022)
Lerato Moeti, Madira Litedu, Jacques Joubert
Common deficiencies found in generic Finished Pharmaceutical Product (FPP) applications submitted for registration to the South African Health Products Regulatory Authority (SAHPRA). Journal of pharmaceutical policy and practice 15 (1) (2022)
Lerato Moeti, Madira Litedu, Jacques Joubert
Bioequivalence Common Deficiencies in Generic Products Submitted for Registration to the South African Health Products Regulatory Authority (SAHPRA). Therapeutic innovation & regulatory science 56 (5) (2022)
Lamya H Al-Wahaibi, Mario A Macías, Olivier Blacque, Luke S Zondagh, Jacques Joubert, Subbiah Thamotharan, María Judith Percino, Ahmed A B Mohamed, Ali A El-Emam
Weak Noncovalent Interactions in Three Closely Related Adamantane-Linked 1,2,4-Triazole N -Mannich Bases: Insights from Energy Frameworks, Hirshfeld Surface Analysis, In Silico 11β-HSD1 Molecular Docking and ADMET Prediction. Molecules (Basel, Switzerland) 27 (21) (2022)
Erika Kapp, Jacques Joubert, Samantha Leigh Sampson, Digby Francis Warner, Ronnett Seldon, Audrey Jordaan, Margaretha de Vos, Rajan Sharma, Sarel F Malan
Antimycobacterial Activity, Synergism, and Mechanism of Action Evaluation of Novel Polycyclic Amines against Mycobacterium tuberculosis. Advances in pharmacological and pharmaceutical sciences 2021 (2021)
Sheunopa C Mzezewa, Sylvester I Omoruyi, Luke S Zondagh, Sarel F Malan, Okobi E Ekpo, Jacques Joubert
Design, synthesis, and evaluation of 3,7-substituted coumarin derivatives as multifunctional Alzheimer's disease agents. Journal of enzyme inhibition and medicinal chemistry 36 (1) (2021)
Lerato Moeti, Madira Litedu, Jacques Joubert
Common Deficiencies Found in the Active Pharmaceutical Ingredient (API) Section of Non-sterile Generic Products Submitted for Registration by SAHPRA. Therapeutic innovation & regulatory science (2021)
Luke S Zondagh, Sarel F Malan, Jacques Joubert
Design, synthesis and biological evaluation of edaravone derivatives bearing the N-benzyl pyridinium moiety as multifunctional anti-Alzheimer's agents. Journal of enzyme inhibition and medicinal chemistry 35 (1) (2021)
Doaa A Osman, Mario A Macías, Lamya H Al-Wahaibi, Nora H Al-Shaalan, Luke S Zondagh, Jacques Joubert, Santiago Garcia-Granda, Ali A El-Emam
Structural Insights and Docking Analysis of Adamantane-Linked 1,2,4-Triazole Derivatives as Potential 11β-HSD1 Inhibitors. Molecules (Basel, Switzerland) 26 (17) (2021)
Ayodeji O Egunlusi, Sarel F Malan, Sylvester I Omoruyi, Okobi Eko Ekpo, Jacques Joubert
4-Oxatricyclo[5.2.1.02,6]dec-8-ene-3,5-dione Derivatives as NMDA Receptor- and VGCC Blockers with Neuroprotective Potential. Molecules (Basel, Switzerland) 25 (19) (2020)
Sethu Ndzibongwana, Samukelo Ngobese, Ahmad Sayed, Ciniso Shongwe, Simon White-Phillips, Jacques Joubert
Structural Analysis, Molecular Modelling and Preliminary Competition Binding Studies of AM-DAN as a NMDA Receptor PCP-Site Fluorescent Ligand. Molecules (Basel, Switzerland) 24 (22) (2019)
Ireen Denya, Sarel F Malan, Adaze B Enogieru, Sylvester I Omoruyi, Okobi E Ekpo, Erika Kapp, Frank T Zindo, Jacques Joubert
Design, synthesis and evaluation of indole derivatives as multifunctional agents against Alzheimer's disease. MedChemComm 9 (2) (2018)
Jacques Joubert
Bicyclic bis-heteroaryl derivatives as inhibitors of the α-synuclein protein: a patent evaluation of WO2018138088A1. Expert opinion on therapeutic patents 28 (12) (2018)